Skip to main content

Role of iNOS and eNOS expression in a group of Egyptian diabetic and nondiabetic nephropathy patients


Introduction and aim

Changes in renal nitric oxide (NO) production have been associated with glomerular hyperfiltration, vascular permeability, albuminuria, glomerulosclerosis, and tubulointerstitial fibrosis. This study aimed at detection of the role of both inducible nitric oxide synthases (iNOS) and endothelial nitric oxide synthases (eNOS) expression in diabetic and nondiabetic nephropathy patients.


Renal biopsies and clinical data of 30 diabetic patients, 10 nondiabetic patients with renal impairment, and 10 control individuals were assessed for eNOS and iNOS expression.


Both glomerular eNOS and iNOS expression levels were increased in diabetic nephropathy patients and this was associated with peripheral arterial occlusive disease. In nondiabetic patients, increased serum creatinine was found to be associated with increased iNOS and eNOS expression, and, together with the control group, they showed increased iNOS expression in tubular and interstitial cells. An association between cigarette smoking and increased expression of both iNOS and eNOS was detected in diabetic patients.


The presence of iNOS is associated with tubular damage resulting in renal failure. The upregulation of NO in diabetes mellitus type 2 may explain the endothelial dysfunction that is associated with almost all diabetic complications.


  1. Remuzzi G, Schieppati A, Ruggenenti P. Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med 2002; 346:1145–1151.

    Article  Google Scholar 

  2. Delles C, Klingbeil AU, Schneider MP. The role of the nitric oxide in the regulation of glomerular hemodynamics in humans. Nephrol Dial Transplant 2004; 19:1392–1397.

    CAS  Article  Google Scholar 

  3. Komer R, Andreson S. Paradoxes of nitric oxide in the diabetic kidney. Am J Physiol Renal Physiol 2003; 284:F1121–F1137.

    Article  Google Scholar 

  4. Heeringa P, Van Goor H, Itoh-Lindstrom Y. Lack of endothelial nitric oxide synthase aggrevates murine accelerated anti-glomerular basement membrane glomerulonephritis. Am J Pathol 2000; 156:879–888.

    CAS  Article  Google Scholar 

  5. Wolf G, Ziyadeh FN. Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 1999; 56:393–405.

    CAS  Article  Google Scholar 

  6. Goligorsky MS. Endothelial cell dysfunction and nitric oxide synthase. Kidney Int 2000; 58:1360–1376.

    CAS  Article  Google Scholar 

  7. Schwartz D, Schwartz IF, Blantz RC. An analysis of renal nitric oxide contribution to hyperfiltration in diabetic rats. J Lab Clin Med 2001; 137:107–114.

    CAS  Article  Google Scholar 

  8. Prabhakar SS. Role of nitric oxide in diabetic nephropathy. Semin Nephrol 2004; 24:333–344.

    CAS  Article  Google Scholar 

  9. Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 2004; 114:5–14.

    CAS  Article  Google Scholar 

  10. Hohenstein B, Hausknecht B, Boehmer K, Riess R, Brekken RA, Hugo CP. Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney Int 2006; 69:1654–1661.

    CAS  Article  Google Scholar 

  11. Nakayama T, Sato W, Kosugi T, Zhang L, Campbell-Thompson M Yoshimura A, et al. Endothelial injury due to eNOS deficiency accelerates the progression of chronic renal disease in the mouse. Am J physiol Renal Physiol 2008; 52:154–178.

    Google Scholar 

  12. Biesenbach G, Grafinger P, Janko O. Influence of cigarette smoking on the progression of clinical diabetic nephropathy in type 2 diabetic patients. Clin Nephrol 1997; 48:146–150.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Mohamed N. Abdalla.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Aly, M.I., Abdalla, M.N., El Akad, M.H. et al. Role of iNOS and eNOS expression in a group of Egyptian diabetic and nondiabetic nephropathy patients. Egypt J Intern Med 25, 33–36 (2013).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


  • diabetic nephropathy
  • eNOS
  • iNOS
  • type 2 diabetes mellitus